---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-027823"
form_type: "8-K"
ticker: "MNOV"
cik: "0001226616"
company_name: "MEDICINOVA INC"
filed_at: "2023-06-14T23:59:59+00:00"
generated_at: "2026-06-14T00:55:22.477567+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Stockholders elect director, ratify auditor, approve 2023 equity plan

## Summary
- Hideki Nagao elected Class I director with 19.7M for, 7.5M against, 1.4M abstain, 2.7M broker non-vote.
- BDO USA, LLP ratified as independent auditor for fiscal 2023: 27.8M for, 2.4M against, 1.1M abstain.
- 2023 Equity Incentive Plan approved: 19.2M for, 7.9M against, 1.5M abstain, 2.7M broker non-vote.
- Meeting held June 13, 2023; 31.3M shares voted of 49.0M outstanding (quorum present).

## SEC filing metadata
- accession: 0000950170-23-027823
- form_type: 8-K
- ticker: MNOV
- cik: 0001226616
- company_name: MEDICINOVA INC
- filed_at: 2023-06-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1226616/000095017023027823/0000950170-23-027823-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1226616/000095017023027823/mnov-20230613.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-027823
- JSON: https://secwatch.observer/filing/0000950170-23-027823.json
- Plain text: https://secwatch.observer/filing/0000950170-23-027823.txt

## Key facts
- Shareholder Votes
  MEDICINOVA INC shareholders approved Approve the Company’s 2023 Equity Incentive Plan, as disclosed in the Proxy Statement. at the 2023-06-13 meeting.
  - Proposal: equity plan
  - Outcome: passed
  - Meeting: 2023-06-13
  source text: To approve the Company’s 2023 Equity Incentive Plan, as disclosed in the Proxy Statement. This proposal was approved, with the votes thereon at the Annual Meeting as follows: Final Voting Results For Against Abstain Broker Non-Vote 19,200,437 7,879,289 1,504,082 2,715,513
  evidence_url: https://www.sec.gov/Archives/edgar/data/1226616/000095017023027823/0000950170-23-027823-index.htm
- Shareholder Votes
  MEDICINOVA INC shareholders approved Ratify the selection of BDO USA, LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2023. at the 2023-06-13 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-06-13
  source text: To ratify the selection of BDO USA, LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2023. This proposal was approved, with the votes thereon at the Annual Meeting as follows: Final Voting Results For Against Abstain Broker Non-Vote 27,807,178 2,362,900 1,129,243 -
  evidence_url: https://www.sec.gov/Archives/edgar/data/1226616/000095017023027823/0000950170-23-027823-index.htm
- Shareholder Votes
  MEDICINOVA INC shareholders approved Election of one Class I Director nominee named below to serve until the 2026 Annual Meeting of stockholders and until their successors have been duly elected and qualified, or, if sooner, until their earlier death, resignation or removal. at the 2023-06-13 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-06-13
  source text: To elect one Class I Director nominee named below to serve until the 2026 Annual Meeting of stockholders and until their successors have been duly elected and qualified, or, if sooner, until their earlier death, resignation or removal. The named nominee was so elected, with the votes thereon at the Annual Meeting as follows: Final Voting Results Nominees For Against Abstain Broker Non-Vote Hideki Nagao 19,685,986 7,517,392 1,380,430 2,715,513
  evidence_url: https://www.sec.gov/Archives/edgar/data/1226616/000095017023027823/0000950170-23-027823-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.